7 employees
CytImmune Sciences focuses on the discovery, development and commercialization of multifunctional, tumor-targeted therapies.
2005
$400K
from 2 investors over 2 rounds
Cytimmune Sciences raised $400K on May 12, 2014
Investors: TEDCO and Montgomery County Department of Economic Development